新基制药(CELG)

tiger-in-motion2017-10-27 04:56

$新基制药(CELG)$ 感觉华尔街的反映有点问题，为什么这么说呢？
之前一个礼拜已经说停止GED301 的CROHN 的3期临床，（实际上这已经和目前下调2020年销售增长约15亿相关）股价当时已经以下跌11%，财报前又顺势下滑约2个多点，今天财报又跌16%点，目前股价距离ALL TIME HIGH 下跌35%。
CEO ...查看全文

RoyalRothschild2017-10-27 03:39

$新基制药(CELG)$ 这个月内，这货创造了两个记录，52周新高，52周新低。真的是....牛股查看全文

10-26 Recap

交易者的天空2017-10-27 02:28

$新基制药(CELG)$ $美第奇新星生物技术(MNOV)$ $TWTRTwitter(TWTR)$
VRX TEVA 哥俩看样子又添一位难兄难弟 CELG, CELG 可以先当大哥，它现在价格最高， 哥儿三可以组个家族了lol
这周本人家里喜事较多，心情不错。分享个“”小电影” CELG 开盘发生了啥
Long term investor 就...查看全文

修道修心养性2017-10-27 00:20

$新基制药(CELG)$ 医药股高风险，，，查看全文

davidweng2017-10-26 23:39

这波美股热门股杀跌不一般那，从中概股到生物科技，只要业绩稍微不如意，毫不留情的杀。刚在听CNBC，现在市场已经转成“earning beat”只涨一点点，“earning miss”就暴跌的“不安模式”，看起来接下来这段时间不会很好过。$新基制药(CELG)$ $好未来(TAL)$查看全文

Alwaleed2017-10-26 23:37

$新基制药(CELG)$ 奇葩的走势，各种低开。查看全文

Arthur_L2017-10-26 23:08

$新基制药(CELG)$ 加仓的良机！查看全文

tiger-in-motion2017-10-26 22:49

$新基制药(CELG)$ 除了再做一笔大的DEAL 或者OTEZLA 又有新的LABEL INDICATION.否则股价最多到110查看全文

尋找52_week_high2017-10-26 21:57

$新基制药(CELG)$ 新基都可以这样跌，买药股真的要审慎查看全文

抄作业的Jack2017-10-26 21:37

$长城汽车(02333)$ 明天应该会比$好未来(TAL)$ $新基制药(CELG)$ 表现好一些吧。查看全文

$新基制药(CELG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013792  Size: 69 KB 网页链接

$新基制药(CELG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013796  Size: 42 KB 网页链接

$新基制药(CELG)$ 15-12B Securities registration termination [Section 12(b)] Accession Number: 0001140361-19-022527  Act: 34  Size: 15 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022225  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022228  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022200  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022201  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022206  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022210  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022217  Act: 33  Size: 39 KB 网页链接